Methotrexate use in rheumatoid arthritis

Rheumatic Disease Clinics of North America

Volumn 23, Issue 4, 1997, Pages 779-796

  O'Dell, J R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; COTRIMOXAZOLE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

BONE MARROW DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; LUNG DISEASE; NAUSEA; PATIENT SELECTION; PRIORITY JOURNAL; RASH; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SCREENING; STOMATITIS;

EID: 0030711570     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70360-4     Document Type: Article

References (92)

1. A. Al-Awadhi P. Dale R.J.R. McKendry Pancytopenia associated with low-dose methotrexate therapy: A regional survey J Rheumatol 20 1993 1121 1125
2. G.S. Alarcón J.M. Kremer M. Macaluso MTX-lung toxicity in RA: A multicenter, case–control study Arthritis Rheum 38 Suppl 9 1995 205
3. G.S. Alarcón A. Lopez-Mendez J. Walter Radiographic evidence of disease progression in methotrexate treated and non-methotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: A meta-analysis J Rheumatol 19 1992 1868 1873
4. G.S. Alarcón I.C. Tracy Blackburn W.D. Jr Methotrexate in rheumatoid arthritis: Toxic effects as the major factor in limiting long-term treatment Arthritis Rheum 32 1989 671 676
5. P.A. Andersen S.G. West J.R. O'Dell Weekly pulse methotrexate in rheumatoid arthritis Ann Intern Med 103 1985 489 496
6. M.H. Arnold J. O'Callaghan M. McCredie Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study Br J Rheumatol 29 1990 120 125
7. T.R. Bachman A.D. Sawitzke S.L. Perkins Methotrexate-associated lymphoma in patients with rheumatoid arthritis: Report of two cases Arthritis Rheum 39 2 1996 325 329
8. B. Bannwarth L. Labat Y. Moride T. Schaeverbeke Methotrexate in rheumatoid arthritis: An update Drugs 47 1994 25 50
9. S. Baumgartner L.W. Moreland M.H. Schiff Double-blind, placebo-controlled trial of tumor necrosis factor receptor (p80) fusion protein (TNFR:Fc) in active rheumatoid arthritis Arthritis Rheum 39 9 Suppl 1996 74
10. S.L.J. Bridges A. López-Méndez K.H. Han Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol 18 1991 984 988
11. P.J. Brooks W.J. Spruill R.C. Parish Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis Arthritis Rheum 33 1990 91 94
12. L.M. Buckley P.M. Vacek S.M. Cooper Administration of folinic acid after low-dose methotrexate in patients with rheumatoid arthritis J Rheumatol 17 1990 1158 1161
13. J.M. Cash J.H. Klippel Second-line drug therapy for rheumatoid arthritis N Engl J Med 330 1994 1368 1375
14. N.J. Cook G.J. Carroll Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis Ann Rheum Dis 51 1992 272 274
15. M.J. Elliott R.N. Maini M. Feldman Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105 1110
16. A.R. Erickson V. Reddy S.A. Vogelgesang Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients Arthritis Rheum 38 1995 1115 1119
17. S. Farber L.K. Diamond R.D. Mercer Temporary remissions in acute leukemia in children produced by folic antagonist 4-amethopteroyl glutamic acid (aminopterin) N Engl J Med 238 1948 787 793
18. D.T. Felson J.J. Anderson R.F. Meenan The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis Arthritis Rheum 33 1990 1449 1460
19. D.T. Felson J.J. Anderson R.F. Meenan Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis: A metaanalysis of published clinical trials Arthritis Rheum 35 1992 1117 1125
20. G.S. Firestein Rheumatoid synovitis and pannus J.H. Klippel Dieppe P. Rheumatology 1994 Mosby Year Book London 1 30
21. D.E. Furst R. Koehnke L.F. Burmeister Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis J Rheumatol 16 1989 313 320
22. R. Gubner S. August V. Ginsberg Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis Am J Med Sci 221 1951 176 182
23. H. Hamdy R.J.R. McKendry E. Mierins Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis Arthritis Rheum 30 1987 361 368
24. P.S. Hanrahan A.S. Russell Concurrent use of folinic acid and methotrexate in rheumatoid arthritis J Rheumatol 15 1988 1078 1080
25. D.L. Hanson Cost-effectiveness of orally administered liquid methotrexate: Comment on letters by McLaughlin and by Wase Arthritis Rheum 37 1994 1713
26. Harris E.D. Jr Rheumatoid arthritis: Pathophysiology and implications for therapy N Engl J Med 322 1990 1277 1289
27. P.S. Hench E.C. Kendall C.H. Slocumb The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis Proc Staff Meet Mayo Clin 24 1949 181 197
28. P.S. Hench E.C. Kendall C.H. Slocumb Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions Arch Intern Med 85 1950 545 666
29. R.A. Herman P. Veng-Pedersen J. Hoffman Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients J Pharm Sci 78 1989 165 171
30. R.T. Hoffmeister Methotrexate in rheumatoid arthritis [abstract] Arthritis Rheum 15 1972 114
31. R.T. Hoffmeister Methotrexate therapy in rheumatoid arthritis: 15 years' experience Am J Med 75 6A 1983 69 73
32. H.A. Isomaki T. Hakulinen U. Joutsenlahti Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis J Chronic Dis 31 1978 691 696
33. M.E.C. Jeurissen A.M.Th. Boerbooms van de Putte L.B.A. Superiority of methotrexate to azathioprine in advanced rheumatoid arthritis: Results of a randomized double-blind trial Arthritis Rheum 33 Suppl 9 1990 S39
34. M.E.C. Jeurissen M.T. Boerbooms van de Putte L.B.A. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis: A randomized, double-blind study Ann Intern Med 114 1991 999 1004
35. D.A. Joyce R.K. Will D.M. Hoffman Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid Ann Rheum Dis 50 1991 913 914
36. O.W. Kamel van de Rijn M. L.M. Weiss Brief report: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis N Engl J Med 328 1993 1317 1321
37. N.E. Karam L. Roger L.L. Hankins Rheumatoid nodulosis of the meninges J Rheumatol 21 1994 1960 1963
38. J.M. Kremer The changing face of therapy for rheumatoid arthritis Rheum Dis Clin North Am 21 1995 845 852
39. J.M. Kremer Liver toxicity does not have to follow methotrexate therapy of patients with rheumatoid arthritis Am J Gastroenterol 92 1997 194 196
40. J.M. Kremer G.S. Alarcón R.W. Alexander Methotrexate (MTX)-lung toxicity: Clinical features of thirty-seven cases from seven rheumatology practices Arthritis Rheum 38 Suppl 9 1995 205
41. J.M. Kremer G.S. Alarcón Lightfoot R.W. Jr Methotrexate for rheumatoid arthritis: Suggested guidelines for monitoring liver toxicity Arthritis Rheum 37 1994 316 328
42. J.M. Kremer J.M.S. Davies R.I. Rynes Every-other-week methotrexate in patients with rheumatoid arthritis Arthritis Rheum 38 1995 601 607
43. J.M. Kremer K.L. Joong A long-term prospective study of the use of methotrexate in rheumatoid arthritis: Update after a mean of fifty-three months Arthritis Rheum 31 1988 577 584
44. J.M. Kremer R.G. Lee K.G. Tolman Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy: A prospective study with baseline and sequential biopsy samples Arthritis Rheum 332 1989 121 127
45. J.M. Kremer C.T. Phelps Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: Update after a mean of 90 months Arthritis Rheum 35 1992 138 145
46. J.M. Kremer R.I. Rynes L.E. Bartholomew Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy Am J Med 82 1987 781 786
47. K. Kwoh L.G. Anderson D.M. Erlandson Guidelines for the management of rheumatoid arthritis Arthritis Rheum 39 1996 713 722
48. A. Lopez-Mendez W.W. Daniel J.C. Reading Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the Cooperative Systemic Studies of the Rheumatic Diseases Program randomized clinical trial of methotrexate, auranofin, or a combination of the two Arthritis Rheum 36 1993 1364 1369
49. C.R. Marks R.F. Willkens K.R. Wilske Small-vessel vasculitis and methotrexate Ann Intern Med 100 1984 916
50. D. Mathers A.S. Russell Methotrexate Dixon Furst D.E. Second-line agents in the treatment of rheumatic diseases 1992 Marcel Dekker New York 287 310
51. D.J. McCarty J.G. Harman J.L. Grassanovich Combination drug therapy of seropositive rheumatoid arthritis J Rheumatol 22 1995 1636 1645
52. P. Morassut R. Goldstein M. Cyr Gold sodium thiomalate compared to low-dose methotrexate in the treatment of rheumatoid arthritis—a randomized double-blind, 26-week trial J Rheumatol 16 1984 302 306
53. S.L. Morgan J.E. Baggott W.H. Vaughn Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis Ann Intern Med 121 1994 833 841
54. S.L. Morgan J.E. Baggott W.H. Vaughn The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis Arthritis Rheum 33 1990 9 18
55. S.L. Morgan J.E. Baggott W.H. Vaughn Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: A double-blind, placebo-controlled trial Ann Intern Med 121 1994 833 841
56. D.M. Nordstrom S.G. West P.A. Andersen Pulse methotrexate therapy in rheumatoid arthritis: A controlled prospective roentgenographic study Ann Intern Med 107 1987 797 801
57. J.R. O'Dell The treatment of rheumatoid arthritis in 1995: Results of a survey Arthritis Rheum 38 Suppl 1995 366
58. J.R. O'Dell Combination DMARD therapy for rheumatoid arthritis: A step closer to the goal Ann Rheum Dis 55 1996 781 783
59. J. O'Dell C. Haire N. Erikson Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications N Engl J Med 334 1996 1287 1291
60. J.R. O'Dell C. Haire N. Erikson Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate J Rheumatol 23 suppl 44 1996 72 74
61. J. O'Dell B. Nepom C. Haire DRB1 typing in rheumatoid arthritis (RA) is useful in predicting response to specific therapy Arthritis Rheum 39 Suppl 1996 305
62. D. Oguey F. Këlliker N.J. Gerber Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis Arthritis Rheum 35 1992 611 614
63. T. Pincus S.B. Marcum L.F. Callahan Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices. II. Second-line drugs and prednisone J Rheumatol 19 1992 1885 1894
64. R. Rau G. Herborn T. Karger A double-blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis J Rheumatol 18 1991 328 333
65. R. Rau G. Herborn T. Karger D. Werdier Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy: A controlled study Arthritis Rheum 34 1991 1236 1244
66. R. Rau G. Herborn T. Karger A double-blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis J Rheumatol 18 1991 328 333
67. T.W. Rooney D.E. Furst Methotrexate ed 2 McCarty Koopman Arthritis and Allied Conditions: A Textbook of Rheumatology Vol 1 1993 Lea & Febiger Philadelphia 621 636
68. R. Segal D. Caspi M. Tishler Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis Arthritis Rheum 31 1988 1182 1185
69. J.B. Shiroky A. Frost J.D. Skeleton Complications of immunosuppression associated with weekly low-dose methotrexate J Rheumatol 18 1991 1172 1175
70. J.B. Shiroky C. Neville J.M. Esdaile Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis Arthritis Rheum 36 1993 795 803
71. R.W. Simms K. Kwoh L.G. Anderson Guidelines for monitoring drug therapy in rheumatoid arthritis Arthritis Rheum 39 1996 723 731
72. L. Slørdal G. Sager J. Aarbakke Pharmacokinetic interactions with methotrexate: Is 7-hydroxy-methotrexate the culprit? Lancet 1 1988 591 592
73. K.A. Stewart A.H. Mackenzie J.D. Clough Folate supplementation in methotrexate-treated rheumatoid arthritis patients Semin Arthritis Rheum 20 1991 332 338
74. K.A. Stewart A.H. Mackenzie W.S. Wilke Folate supplementation in methotrexate-treated rheumatoid arthritis patients Semin Arthritis Rheum 20 1991 332 338
75. M. Suarez-Almozaor A. Fitzgerald M. Grace A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis J Rheumatol 15 1988 753 756
76. R. Thoburn P. Katz Lymphoproliferative disease in patients with autoimmune disease on low-dose methotrexate Am Coll Rheumatol Hotline June 1, 1995
77. R.N. Thompson C. Watts J. Edelman A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis J Rheumatol 11 1984 760 762
78. P. Tugwell K. Bennett M. Gent Methotrexate in rheumatoid arthritis Ann Intern Med 107 1987 358 366
79. P. Tugwell T. Pincus D. Yocum Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis N Engl J Med 333 1995 137 141
80. M.E. Weinblatt Methotrexate (MTX) in rheumatoid arthritis (RA): A 5-year multicenter prospective trial Arthritis Rheum 36 1993 S79
81. M.E. Weinblatt J.S. Cobby D.A. Fox Efficacy of low-dose methotrexate in rheumatoid arthritis N Engl J Med 312 1985 818 822
82. M.E. Weinblatt P. Fraser Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy Arthritis Rheum 32 1989 1592 1596
83. M.E. Weinblatt H. Kaplan B.F. Germain Methotrexate in rheumatoid arthritis: A five-year prospective multicenter study Arthritis Rheum 37 1994 1492 1498
84. M.E. Weinblatt H. Kaplan B.F. Germain Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis Arthritis Rheum 33 1990 330 338
85. M.E. Weinblatt H. Kaplan B.F. Germain Methotrexate in rheumatoid arthritis: Effects on disease activity in a multicenter prospective study J Rheumatol 18 1991 334 338
86. M.E. Weinblatt R.P. Polisson S.D. Blotner The effects of drug therapy on radiographic progression of rheumatoid arthritis: Results of a 36-week randomized trial comparing methotrexate and auranofin Arthritis Rheum 36 1993 613 619
87. M.E. Weinblatt B.N. Weissman D.E. Holdsworth Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84-month update Arthritis Rheum 35 1992 129 137
88. W.S. Wilke L.H. Calabrese A.L. Scherbel Methotrexate in the treatment of rheumatoid arthritis Cleve Clin Q 47 1980 305 309
89. H.J. Williams R.F. Willkens C.O. Samuelson Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis—a controlled clinical trial Arthritis Rheum 28 1985 721 729
90. R.F. Willkens J.T. Sharp D. Stablein Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis Arthritis Rheum 38 1995 1799 1806
91. R.F. Willkens M.A. Watson C.S. Paxson Low-dose pulse methotrexate therapy in rheumatoid arthritis J Rheumatol 7 1980 501 505
92. F. Wolfe The epidemiology of drug treatment failure in rheumatoid arthritis Clin Rheumatol 9 1995 619 632